← board
SYBX
distress 1/10 · well-funded / low risk$0.71+1%today-61% from 52w high
Revenue
pre-revenue
Liquidity
$14M
Runway
4.3 yrs
Shares 1y
0%
Price & events
+24.5% over 6M
CatalystRating changeDilutionFinancingdashed = today
+0.9%
1D
+1.4%
1W
-1.3%
1M
+13.4%
3M
+24.5%
6M
-55.6%
1Y
-56.6%
2Y
-98.5%
5Y
-97.8%
All
Overview
- Market Cap
- $8.32M
- Volume
- 4.30K
- 52 Week Range
- $0.56 – $1.83
- Total Shares
- 11.70M
- Float Shares
- 6.40M
- Short %
- 0.20%
- % Held by Insiders
- 16.39%
- % Held by Institutions
- 35.28%
- RVOL
- 0.36x
- Beta
- 0.54
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.